Shareholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands					2 Months Ended	3 Months Ended		12 Months Ended
	Jan. 27, 2025	Nov. 21, 2024	Feb. 08, 2024	Feb. 06, 2024	Jan. 27, 2025	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	May 14, 2024	Feb. 29, 2024	Dec. 31, 2021
Subsidiary or Equity Method Investee [Line Items]
Preferred stock, shares authorized								2,000,000	2,000,000
Preferred stock, no par value								$ 0	$ 0
Preferred stock, shares issued								0	0
Preferred stock, shares outstanding								0	0
Common stock, shares authorized								450,000,000	450,000,000
Common stock, no par value								$ 0	$ 0
Shares issued through registered direct financings, shares		31,578,951			39,473,688
Common stock, shares issued								220,416,326	174,986,671
Common stock, shares outstanding								220,416,326	174,986,671
Warrant exercisable into common share		1
Warrants and rights expiry date		May 21, 2028
Proceeds from sale of common shares with warrants		$ 24,000
Stock issuance costs		2,300
Fair value of warrant liabilities		$ 7,900						$ 6,161
Combined purchase price of common stock and warrants	$ 0.76	$ 0.76			$ 0.76
Date of warrants exercisable		May 21, 2025
Class of warrant or right, number	39,473,688	31,578,951			39,473,688
Exercise price per share		$ 0.91
Fair value of warrant liabilities								$ (2,128)	$ 0
Broadwood Partners, L.P [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock				6,730,770
Broadwood Partners, L.P [Member] | Subsequent Event
Subsidiary or Equity Method Investee [Line Items]
Shares issued through registered direct financings, shares	7,894,737
Warrant exercisable into common share	1				1
Warrants and rights expiry date	May 21, 2028				May 21, 2028
Proceeds from sale of common shares with warrants	$ 6,000
Stock issuance costs	$ 500
Combined purchase price of common stock and warrants	$ 0.76				$ 0.76
Date of warrants exercisable	May 21, 2025
Class of warrant or right, number	7,894,737				7,894,737
Exercise price per share	$ 0.91				$ 0.91
H.C. Wainwright & Co., LLC [Member]
Subsidiary or Equity Method Investee [Line Items]
Fair value of warrant liabilities		$ 400
Aggregate cash fee percentage								7.00%
Percentage of management fee of aggregate gross proceeds								1.00%
Class of warrant or right, number	1,973,684				1,973,684
Exercise price per share								$ 0.95
H.C. Wainwright & Co., LLC [Member] | Subsequent Event
Subsidiary or Equity Method Investee [Line Items]
Class of warrant or right, number	394,736				394,736
Parent Company [Member]
Subsidiary or Equity Method Investee [Line Items]
Sale of stock				13,461,540
Sale of Stock, Price Per Share				$ 1.04
Sales Agreement [Member] | Parent Company [Member]
Subsidiary or Equity Method Investee [Line Items]
Equity securities available for sale								$ 39,970
February 2024 Registered Direct Offering | Parent Company [Member]
Subsidiary or Equity Method Investee [Line Items]
Proceeds from sale of common shares with warrants			$ 14,000
Stock issuance costs			$ 100
Prior Sales Agreement [Member] | Parent Company [Member]
Subsidiary or Equity Method Investee [Line Items]
Common stock, shares issued											4,912,803
Weighted average price per share issuance of common stock							$ 1.23
Net proceeds												$ 64,100
Sale of stock							30,000
Weighted average price per share											$ 1.41
Gross proceeds from issuance of common stock											$ 6,900
Gross proceeds from issuance of common stock							$ 37,000
ATM Sales Agreement [Member] | B. Riley Securities, Inc. [Member]
Subsidiary or Equity Method Investee [Line Items]
Percentage of commission payable								3.00%
ATM Sales Agreement [Member] | Parent Company [Member]
Subsidiary or Equity Method Investee [Line Items]
Weighted average price per share issuance of common stock						$ 1.3
Net proceeds							$ 40,000			$ 39,970
Sale of stock						25,830
Gross proceeds from issuance of common stock						$ 33,000
Equity securities available for sale								$ 39,970